is wegovy a glp 1 drug Arrival of GLP-1 weight-loss pill new headache for food makers Oksana Aron, M.D., Medical Weight

The Loss of Exclusivity (LOE) of semaglutide in China, Brazil, Canada and India in 2026 will result in the availability of cheaper generics in these countries (and possibly neighbouring countries via parallel import)

SGLT2 inhibitors: from glucose-lowering to cardiovascular benefits

Research shows that people with type 2 diabetes and obesity lost an average of 5% to 6% of their body weight after taking Ozempic for a year

Bell GI, Sanchez-Pescador R, Laybourn PJ, and Najarian RC

In conclusion, GLP-1 improves cognitive function by engaging multiple signaling pathways, including CREB, PI3K/Akt, mTOR, and SIRT1

MDL 3094 consolidates federal lawsuits against Novo Nordisk (maker of Ozempic, Rybelsus, Wegovy) and Eli Lilly (maker of Trulicity and Mounjaro)